Search

Your search keyword '"Aldape, Kenneth"' showing total 522 results

Search Constraints

Start Over You searched for: Author "Aldape, Kenneth" Remove constraint Author: "Aldape, Kenneth" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
522 results on '"Aldape, Kenneth"'

Search Results

1. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

3. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

6. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities

7. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature

10. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome

11. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas

12. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

13. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

14. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis

16. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1

17. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases

18. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion

20. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups

23. Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

25. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas: Guideline From the College of American Pathologists in Collaboration With the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology

27. Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes

28. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13

29. MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

31. Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach.

32. A clinically applicable integrative molecular classification of meningiomas

33. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

34. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

37. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

38. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?

43. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt

45. Longitudinal molecular trajectories of diffuse glioma in adults

47. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.

48. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case.

49. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer

50. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma

Catalog

Books, media, physical & digital resources